← Back to Patent Explorer
US5605837A Expired / Lapsed US ⏱️ 0.0 years remaining

Control solution for a blood glucose monitor

Assignee: LifeScan Inc
•
Filing: 1996-02-14
•
Granted: 1997-02-25
•
Expires: 2016-02-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A control solution for use with a photometric blood glucose strip contains glucose in an aqueous suspension of carbon black. The control solution mimics blood when applied to a whole blood glucose test strip, which is then inserted into a meter. A meter reading within a predetermined range indicates that meter and strip are operating satisfactorily. Preferably the control solution is buffered to a neutral pH and includes chloride ion to provide a stable end point for the glucose reaction. Depending on the glucose concentration, the solution checks meter and strip operation at high, low, and normal blood glucose levels.

Inventors

  • 👤 Saker A. Karimi
  • 👤 Geoffrey McGarraugh
  • 👤 Yeung S. Yu

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 02:39
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/96; G01N33/66; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/104998; Y10T436/106664

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 40 words
The control solution that mimics whole blood for use with a photometric blood glucose strip, which comprises a suspension of opaque iron oxide or carbon water, a dispersant to keep the particles in suspension, and a predetermined concentration of glucose.
Claim 2
Dependent Claim 40 words
The control solution that mimics whole blood for use with a photometric blood glucose strip, which comprises a suspension of opaque iron oxide or carbon water, a dispersant to keep the particles in suspension, and a predetermined concentration of glucose.
Claim 3
Dependent Claim 14 words
The control solution of claim 1 in which the opaque particles comprise carbon particles.
Claim 4
Dependent Claim 18 words
The control solution of claim 2 in which the concentration of particles is at least about 0.015% w/v.
Claim 5
Dependent Claim 20 words
The control solution of claim 2 in which the particles are substantially spherical, with a diameter of about 40 nm.
Claim 6
Dependent Claim 34 words
The control solution of claim 1 further comprising an end point stablizer, which stablizes absorbance of 660 nm radiation by the control solution a predetermined time after contact with a photometric blood glucose strip.
Claim 7
Dependent Claim 15 words
The control solution of claim 5 in which the end point stabilizer is chloride ion.
Claim 8
Dependent Claim 23 words
The control solution of claim 6 in which the chloride ion concentration is in a range from about 0.1% to about 0.25% w/v.
Claim 9
Dependent Claim 16 words
The control solution of claim 7 in which the chloride ion concentration is about 0.20% w/v.
Claim 10
Dependent Claim 10 words
The control solution of claim 1 further comprising a buffer.
Claim 11
Dependent Claim 12 words
The control solution of claim 9 in which the buffer comprises EDTA.
Claim 12
Dependent Claim 25 words
The control solution of claim 9 in which the buffer maintains the solution at a pH in a range from about 6.5 to about 7.5.
Claim 13
Dependent Claim 10 words
The control solution of claim 1 further comprising an antifreeze.
Claim 14
Dependent Claim 12 words
The control solution of claim 12 in which the antifreeze comprises glycerol.
Claim 15
Dependent Claim 10 words
The control solution of claim 1 further comprising a preservative.
Claim 16
Dependent Claim 13 words
The control solution of claim 14 in which the preservative is imidazolidinyl urea.
Claim 17
Dependent Claim 18 words
The control solution of claim 15 in which the imidazolidinyl urea concentration is at least about 0.07% w/v.

References Cited (Backward Citations)

US3558522A Cited
US3920580A Cited
US3960740A Cited
US4729959A Cited
US4935346A Cited
US5304468A Cited
US5308767A Cited
US5306623A Cited
US5028542A Cited
US5187100A Cited
US5296377A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-02-25 2000-08-26 2001-02-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-02-25 2004-08-26 2005-02-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-02-25 2008-08-26 2009-02-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag